Dreamstime 111800761

eBook: Solid dose trends 2023

July 18, 2023

The industry’s most established dosage forms, solid dose drugs are shelf stable and easy to administer. But today's drug formulations are complex and high potency, and OSD drugmakers must continue to innovate manufacturing processes if they want to keep up.

In this eBook, you will gain insight on:

  • Streamlining development of high potency APIs
  • The future of U.S. generics
  • A pending titanium dioxide ban
  • Ensuring tablet integrity
  • The maturing of continuous manufacturing 
This content is sponsored by: Natoli Enginerring Company
  Nilfisk Industrial Vacuums


Travere to axe 20% of workforce

Dec. 6, 2023
Amid regulatory challenges, the biotech is letting go non-field-based employees.

Bringing down the barriers to process monitoring in biopharma

Dec. 6, 2023
How modern process analytical technologies such as Raman spectroscopy can improve quality control

Merck KGaA blockbuster hopeful BTK drug fails in MS trials

Dec. 6, 2023
Two phase 3 trials investigating evobrutinib did not meet primary endpoints

CRISPR Therapeutics to expand into autoimmune disease

Dec. 5, 2023
The announcement comes days before the FDA's regulatory decision on the CRISPR-based gene-therapy exa-cel.